Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy. (2022)

First Author: Muñoz-Moreno JA

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/qad.0000000000003121

PubMed Identifier: 34750296

Publication URI: http://europepmc.org/abstract/MED/34750296

Type: Journal Article/Review

Volume: 36

Parent Publication: AIDS (London, England)

Issue: 3

ISSN: 0269-9370